Celularity
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celularity and other ETFs, options, and stocks.About CELU
Celularity, Inc. is a clinical stage biotechnology company, which engages in the development of off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. It operates through the following segments: Cell Therapy, BioBanking, Degenerative Disease, and Other.
CEORobert Joseph Hariri Gordon
CEORobert Joseph Hariri Gordon
Employees123
Employees123
HeadquartersFlorham Park, New Jersey
HeadquartersFlorham Park, New Jersey
Founded2016
Founded2016
Employees123
Employees123
CELU Key Statistics
Market cap37.39M
Market cap37.39M
Price-Earnings ratio-0.41
Price-Earnings ratio-0.41
Dividend yield—
Dividend yield—
Average volume66.60K
Average volume66.60K
High today$1.38
High today$1.38
Low today$1.30
Low today$1.30
Open price$1.34
Open price$1.34
Volume69.49K
Volume69.49K
52 Week high$4.35
52 Week high$4.35
52 Week low$1.00
52 Week low$1.00
Stock Snapshot
Celularity(CELU) stock is priced at $1.32, giving the company a market capitalization of 37.39M. It carries a P/E multiple of -0.41.
As of 2025-12-17, Celularity(CELU) stock has fluctuated between $1.30 and $1.38. The current price stands at $1.32, placing the stock +1.5% above today's low and -4.1% off the high.
Celularity(CELU) shares are trading with a volume of 69.49K, against a daily average of 66.6K.
During the past year, Celularity(CELU) stock moved between $1.00 at its lowest and $4.35 at its peak.
During the past year, Celularity(CELU) stock moved between $1.00 at its lowest and $4.35 at its peak.
People also own
Based on the portfolios of people who own CELU. This list is generated using Robinhood data, and it’s not a recommendation.